RENEE ORLANDO-HART: Open Payments
NPI 1699730010 · WESTMINSTER, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$955 in 51 payments from 10 companies in 2025. Trend: 2023 $1,063 · 2024 $766 · 2025 $955
Food & beverage: $955
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 10 | $169 |
| ABBVIE INC. | 11 | $148 |
| AstraZeneca Pharmaceuticals LP | 7 | $146 |
| Novo Nordisk Inc | 6 | $122 |
| Exact Sciences Corporation | 4 | $98 |
| Lilly USA, LLC | 4 | $69 |
| Axsome Therapeutics, Inc. | 3 | $68 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $50 |
| Amgen Inc. | 2 | $43 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $42 |
Products named: NURTEC ODT, UBRELVY, Auvelity, Ozempic, MOUNJARO, JARDIANCE, Cologuard Collection Kit, The Cologuard Plus Collection Kit.
Industry payments across MD — which companies pay providers there.
